Skip to main navigation

ABOUT US

Management
Board of Directors

CLINICAL PROGRAMS

Overview
Research & Development
IDO Pathway & Indoximod
Posters & Publications

COLLABORATION

Industry
Advocacy

CAREERS

Culture
Benefits
Jobs

INVESTORS & MEDIA

Investor Relations

Investor Relations
Press Releases
Events & Presentations
Posters & Publications
Corporate Governance
Financial Information
- SEC Filings
- Quarterly Results
Analyst Coverage
Investor FAQs

Contact us

Investors & Media

Home > Investor Relations > Quarterly Results

Quarterly Results

Show all

2018

First Quarter

NewLink Genetics Reports First Quarter 2018 Financial Results
First Quarter 2018 Earnings Conference Call

2017

Fourth Quarter

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs
Fourth Quarter 2017 Earnings Conference Call
Form 10-K

Third Quarter

NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program
Third Quarter 2017 Earnings Conference Call
Form 10-Q

Second Quarter

NewLink Genetics Reports Second Quarter 2017 Financial Results and Updates Indoximod Program
Second Quarter 2017 Earnings Conference Call
Form 10-Q

First Quarter

NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance
First Quarter 2017 Earnings Conference Call
Form 10-Q

2016

Fourth Quarter

NewLink Genetics Provides Operational &amp; Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results
Fourth Quarter 2016 Earnings Conference Call
Form 10-K

Third Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial Results
Third Quarter 2016 Earnings Conference Call
Form 10-Q

Second Quarter

NewLink Genetics Reports Second Quarter 2016 Financial Results
Second Quarter 2016 Earnings Conference Call
Form 10-Q

First Quarter

NewLink Genetics Reports First Quarter 2016 Financial Results
Form 10-Q

2015

Fourth Quarter

NewLink Genetics Provides Operational Update and Reports Fourth Quarter, Year End 2015 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2015 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Provides Operational Update and Reports First Quarter 2015 Financial Results
Form 10-Q

2014

Fourth Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Fourth Quarter and Year End 2014 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Reports First Quarter 2014 Financial Results
Form 10-Q

2013

Fourth Quarter

NewLink Genetics Corporation Reports Fourth Quarter and Year End 2013 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Reports Third Quarter 2013 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Reports Second Quarter 2013 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Reports First Quarter 2013 Financial Results
Form 10-Q

2012

Fourth Quarter

NewLink Genetics Reports Fourth Quarter and Full-Year 2012 Financial Results

Third Quarter

NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Reports Second Quarter 2012 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Reports First Quarter 2012 Financial Results
Form 10-Q

2011

Fourth Quarter

NewLink Genetics Corporation Reports Fourth Quarter and Full-Year 2011 Financial Results
Form 10-K

Shareholder Tools

Email Alerts Subscription
Download Library
Print
Share

Facebook
Google
LinkedIn
Twitter
RSS

About Us
Management
Board of Directors

Clinical Programs
Overview
Research & Development
IDO Pathway & Indoximod
Posters & Publications

Collaboration
Industry
Advocacy

Careers
Culture
Benefits
Jobs

Investors and Media

Investor Relations

Investor Relations
Press Releases
Events & Presentations
Posters & Publications
Corporate Governance
Financial Information
- SEC Filings
- Quarterly Results
Analyst Coverage
Investor FAQs

©2018 NewLink Genetics Corporation. All rights reserved.

Terms & Conditions | Privacy Policy | Contact Us